Injection of drugs from other sources: You can bill for administration, Medicare says

Article Overview

This article covers a Medicare policy clarification affecting billing for administration of covered injectable drugs that are not usually self-administered. It is relevant to physician practices, coders, and billing staff who handle office-administered medications and need to understand how Medicare treats drugs obtained through other channels, including no-cost supply situations. The discussion centers on a policy change and its implications for administration billing under Medicare guidance.